Digital Therapeutic

An app-based digital therapeutic was “largely effective” in reducing symptoms and improving quality of life, work productivity and health literacy among patients with irritable bowel syndrome, according to late-breaking data from UEG Week.

The 2023 Cardiometabolic Health Congress will return in-person to Boston with the latest updates spanning all aspects of cardiometabolic health, including CVD, diabetes, kidney disease, lipid and lifestyle management and obesity.

Digital education through CheckedUp interactive screens resulted in better understanding of glaucoma and glaucoma interventions as compared with verbal information, according to a poster presentation at Real World Ophthalmology.

The FDA granted class II 510(k) clearance to Sleepiz One+, a contactless remote patient monitoring device that tracks respiration rate, heart rate and movement while at rest, according to a manufacturer-issued press release.

HONOLULU — Analyzing real-world digital inhaler data using expert-consensus thresholds on reliever medication use helped find medication overuse and may predict exacerbations, according to an abstract presented at the CHEST Annual Meeting.

VIENNA — Empathy and a caring environment are core in the practice of medicine, and this also applies to the way physicians interact with patients digitally, according to Vance Thompson, MD.

Zerigo Health has appointed Lisa Rometty as its new CEO, according to a company release.

The FDA granted marketing authorization for a digital cognitive behavioral therapy intervention for adults with type 2 diabetes, according to an industry press release.

WASHINGTON — In this video from the Digital Therapeutics Alliance Summit, Mahnu Davar, JD, discusses regulatory challenges faced by emerging technologies including artificial intelligence.

WASHINGTON — In this video, Andy Molnar, CEO of the Digital Therapeutics Alliance, shares plans for next year’s summit.